---
schema_version: "secwatch.filing_event.v1"
accession: "0001171520-26-000304"
form_type: "8-K"
ticker: "SOTK"
cik: "0000806172"
company_name: "SONO TEK CORP"
filed_at: "2026-10-14T11:10:15+00:00"
generated_at: "2026-10-14T11:15:05.529039+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sono-Tek Q2 FY27 sales up 1% to $5.23M; H1 revenue +6% as medical sales jump 289%

## Summary
- H1 net sales rose 6% to $10.89M; gross margin expanded to 55% from 51%; operating income +41% to $1.28M; net income +22% to $1.11M.
- Q2 net sales $5.23M (+1% YoY); net income $366K, or $0.02 per diluted share, down from $424K/$0.03; operating income $382K vs $421K.
- Medical market sales up 289% to $7.05M in H1 and 209% to $3.11M in Q2 on balloon coating and stent-coating system shipments.
- Alternative/clean energy sales fell 85% to $855K in H1 amid U.S. clean-energy policy shifts; electronics/microelectronics down 14%.
- Cash $17.7M and no debt at Aug 31; backlog $9.51M (+23% sequentially); three post-quarter orders worth ~$7.19M shipping in FY28; FY27 guidance reiterated at flat to modest growth.

## SEC filing metadata
- accession: 0001171520-26-000304
- form_type: 8-K
- ticker: SOTK
- cik: 0000806172
- company_name: SONO TEK CORP
- filed_at: 2026-10-14T11:10:15+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806172/000117152026000304/0001171520-26-000304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806172/000117152026000304/eps12886_sotk.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171520-26-000304
- JSON: https://secwatch.observer/filing/0001171520-26-000304.json
- Plain text: https://secwatch.observer/filing/0001171520-26-000304.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.